revuforj - revumenib tablet, film coated
(Revumenib)Syndax Pharmaceuticals, Inc.
Usage: REVUFORJ treats relapsed or refractory acute leukemia with a KMT2A gene translocation and relapsed or refractory acute myeloid leukemia (AML) with a susceptible NPM1 mutation in adults and pediatric patients 1 year and older.